Our esteemed friends and colleagues who recognise the importance of the project.
Göran Hermerén is professor emeritus of medical ethics, Lund University, Sweden. From 2002 to 2011 President of the European Group on Ethics in Science and New Technologies, Brussels, he is currently a member of the National Council on Medical Ethics, Stockholm and chair of the permanent working group for science and ethics of ALLEA (All European Academies). He has served on many governmental commissions in Sweden. In addition, he has served as external examiner in bioethics at the National University of Ireland, as a referee for international journals, and is involved in several on-going EU-funded research projects. He has published books and papers on research ethics, ethics of stem cell research, the goals of medicine and priority setting in health care and contributed to many encyclopaedias.
Brian Ager is Secretary General ERT, European Round Table of Industrialists. Prior to this he was Director General of EFPIA, the European Federation of Pharmaceutical Industries and Associations, the federation of the national pharmaceutical industry associations of 16 West European countries, and companies undertaking research, development and manufacturing of medicinal products in Europe for human use.
For five years he was Director of EUROPABIO (then called Senior Advisory Group Biotechnology), a Brussels based industry forum addressing policy issues affecting biotechnology in Europe. He has also served with the European Commission’s Directorate General for Science, Research and Development and as a consultant with the OECD.
His background includes ten years in the UK Government’s Health and Safety Executive firstly as a Specialist Inspector of health and safety and then as Secretary to the UK’s Advisory Committee on Genetic Manipulation. Before that he held posts at the UK Department of Health and in a National Health Service hospital as a clinical biochemist.
He holds a B.A. (Hons) in Biological Chemistry.
Dr. Mary Baker, MBE, is Immediate Past President of the European Brain Council and President of their ‘Year of the Brain’ project. Mary is Past President of the European Federation of Neurological Associations, Consultant to the World Health Organisation (WHO), Chair of the Working Group on Parkinson’s Disease, a member of the Strategic Advisory Board of the Human Brain Project, and a member of the Commission’s CONNECT Advisory Forum. Academic appointments include Associate Membership of the Health Services Research Unit, University of Oxford and Visiting Fellow within the London School of Economics (LSE) Health Centre.
An Honorary Doctorate from the University of Surrey was conferred upon Mary in 2003 and an Honorary Doctor of Science degree was awarded by Aston University in July 2013. In 2009 she received the prestigious British Neuroscience Association Award for Outstanding Contribution to British Neuroscience and for Public Service. In 2014, Mary received the Dana/EDAB Lifetime Achievement Award for Outreach on Behalf of Brain Research.
Mary graduated from the University of Leeds with a BA Hons in Sociology and Political Theory.
Inez de Beaufort is professor of health care ethics and head of the department of medical ethics and philosophy of medicine at the Erasmus Medical Centre in Rotterdam, the Netherlands. She has published on different subjects in medical ethics, e.g. human research, reproductive technologies, personal responsibility for health, the elderly (euthanasia and dementia) and public health issues. Present research themes of the department are ethics and obesity, transplantation ethics, ethics and paediatrics, ethics and beauty, and medical ethics in literature and films. She has been a member of many ethics committees of hospitals and of national organizations. She is currently a member of the European Group on Ethics in Science and New Technologies, an Honorary member of the Dutch Health Council, and member of the Dutch National Committee for Ethics and Medical Research, member of the Advisory Committee on the Health Care Insurance Package and different other advisory boards.
Ludger Honnefelder is a philosopher and professor emeritus of philosophy at the University of Bonn. He was from 1972-82, first lecturer, then o Professor of Philosophy at the Faculty of Theology of Trier, from 1982 to 1988 professor of philosophy at the Freie Universität Berlin. Since 1988 Professor of Philosophy and Director of the Department of Philosophy, teaching and research II of the University of Bonn. (Emeritus at 1. 4. 2001)
Associate Member of the Kennedy Institute of Ethics, Georgetown University Washington, 1988. Speaker of the Research Working Group on Bioethics in NRW, 1989. Member of the Academy for Ethics in Medicine, 1989. Member of the North Rhine-Westphalia. Academy of Sciences, 1992. Member of the German delegation to the Council of Europe Steering Committee on Bioethics (CDBI), 1992. Director of the Institute for Science and Ethics, Bonn, 1993. Member of the Hegel-Commission of the North Rhine-Westphalia. Academy of Sciences, 1993. Managing Director of the German Reference Centre for Ethics in the Life Sciences, 1998. Member of the Standing Committee "Science & Ethics" of All European Academies (ALLEA), 1998. Member of the Academia Europaea, Salzburg.
Noëlle Lenoir is a French stateswoman. She graduated from the Institut d'Études Politiques de Paris and the Paris Law School and has been a professor in each of these institutions. After qualifying as a lawyer and the achievement of the Senate administrator competition, she has been appointed, from 1972 to 1982, at the law Committee of the French Senate where she was in charge of the follow-up and review of criminal law text related to immigration, in addition to the Justice budget. Following 10 years at the High Assembly, Noelle Lenoir joined the regulation management of the newly formed National Commission for Information Technology and Civil Liberties (Commission Nationale de l’Informatique et des Libertés (CNIL)) as Director of regulatory matters, from 1982 until 1984. In 1984, she joined the Council of State (the Conseil d’état is the French administrative supreme court) and was appointed as Chief of Staff of the Ministry of Justice in 1988, where she served until 1990.
Besides being a constitutional judge, Noelle Lenoir chaired the International Committee on Bioethics of UNESCO and drafted the Human Genome and Human Rights Declaration, which the United Nations endorsed in 1998 on the 50th anniversary of the Universal Declaration of Human Rights. In 1991, she is also appointed by the European Commission presided by Jacques Delors as a member of the European Ethics and Science & Technology Group (GEE). From 1992 to 2001, Noelle Lenoir chaired the European Group on Ethics in Science and New Technologies for the European Commission.
She is the Founder and President of “Cercle des Européens”. A Think Tank which operates as ideas exchange group on socioeconomic and political stakes of the 21st century Europe and which is deemed as a place where managers can meet European decision makers for roundtables on different European problems and subjects. She is also a member of the EC High Level Experts group on the European company law at the Commission level.
Nathalie Moll is the Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA). EFPIA represents the pharmaceutical industry operating in Europe.
Nathalie previously worked as the Secretary General of EuropaBio ranked as the most effective European Trade Association in Brussels in 2013.
After graduating with Honours in Biochemistry and Biotechnology from St Andrews University, Scotland, and a stage at the European Commission, Nathalie has spent 20 years working for the biotech industry at EU and national level in associations and corporate positions.
Within EuropaBio, Nathalie held the posts of External Relations Manager, Director for Strategic Policy, Director for Healthcare Biotech, Director for Agricultural Biotech sector and was the Secretary General from 2010 to 2017. Nathalie, who held the position of Vice Chair of the International Council of Biotech Associations (ICBA) since its inception in 2014 to 2016, was elected Chair of the ICBA in June 2016 for a 2 year term.
In 2013, Nathalie won the Technovisionaries Women Innovation Award organised by Women & Technologies® while in 2009, Nathalie and the Green Biotech Team at EuropaBio were presented with the Leadership and Excellence in Advancing Ag-Biotech and Food Issues Award. Nathalie was also named one of the 15 leading women in biotech in Europe in 2017.
Janek Musek, PhD, is professor for General Psychology at the Faculty of Arts, University of Ljubljana, where he teaches several courses at undergraduate and postgraduate level. He researches and teaches in particular in the areas of personality, values, ethical standards and virtues, wisdom, cognitive psychology, psychology, psychological well-being and health, symbolism, decision-making and the history of psychology, between its narrow research topics belong in addition to the above, the development and formation of a stable society of the future (the company's values, knowledge and wealth or wisdom society).
At home and abroad he published more than 500 articles, of which over 100 scientific, and 49 books. Among them scientific monograph Personality (1982), Nature and Determinants of conscious decision-making (1985), Theories of Personality (1988), Symbols, culture, people (1990), Science image figures (1993), New psychological theory of value (2000), History of Psychology (2003), Psychological and cognitive personality studies (2003), Psychological dimensions of personality (2005) Psychology and Life (2010).
At home and abroad he has aroused attention in his research and theories of values, models and theories of personality structure, recently in particular the general factor model of personality, talks about the last mentioned book. It is among the most cited Slovenian scientists, led and participated in many research projects. He actively participated in numerous national and international scientific conferences and congresses and was a coordinator or organizer of several national and international scientific congresses.
Maurizio Salvi holds a PhD on Health Sciences, a European PhD in biotechnology, a University Degree in Modern Literature, a University Degree in Philosophy a post degree specialization diploma in Bioethics.
In 1998 he joined the European Commission, (Directorate -General Research) as a Scientific Officer responsible for both Bioethics research and policy actions on different fields of research (ELSA aspects).
From 2001 to 2006 he was the deputy Head of the Unit on Ethics and science at the European Commission with specific responsibilities on policy aspects of ethics and science at both EU and International level, including the design and implementation of the Ethics frame to adopt in FP6 and FP7. Between other things, Dr Salvi was the Secretary of the European Union Forum of National Ethics Committees (NEC Forum). He has published extensively on bioethics, ethics and biotechnology and philosophy of biology in Europe, USA, Japan, South America and New Zealand and was a member of the Drafting Working Group of several EC policy papers (from the ERA strategy to Nanotechnology strategy, from Science and Society Strategy to the Life sciences strategy, from the Commission working paper on human embryonic stem cells to several protocols to the Bioethics Convention of the Council of Europe). Dr. Salvi has organised around 30 international EC meetings of different kind and nature, from large conferences (e.g. EC conference on genetic testing and research ethics committees) to inter-institutional events (e.g. the inter-institutional seminar on bioethics –EC, Council and EP), from target workshops (e.g. EU-USA workshop on ethics, law and biometrics or the workshop on capacity building on research ethics in developing countries) to Meetings of the NEC Forum hosted by the rotation Presidencies.
Dr. Salvi is member of several associations on bioethics and gave lectures on ethics and science in the EU, Japan and USA.
Prof. Guido Van Steendam is professor in the Philosophy of Technology at the Higher Institute of Philosophy of the KU Leuven, University of Leuven (Belgium) and is directing the research of the International Forum for Biophilosophy. His research interests include the philosophy and ethics of biomedical developments (such as genetics, biotechnology, reproductive technologies, euthanasia and critical care medicine) as well as Information and Communication Technologies (such as Ambient Intelligence, camera surveillance, social media) and converging technologies. His research has two major components. An operational component is intended to clarify the work of engineers and politicians and others who are designing, analyzing and regulating technology and is organized in close interaction with the actors involved. A methodological component reflects on the theoretical and institutional possibilities and limits to monitor the development of science and technology. Guido Van Steendam has an academic background in natural and human sciences, theology and philosophy.